Structural Biology Aids the Research of New Anti-COVID-19 Drugs.

Lu, Jing; Liu, Xinqi

Lu, Jing; Liu, Xinqi.

Lu J; State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin, China.
Liu X; State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin, China.

Curr Org Synth ; 17(3): 162-163, 2020.

Article in English | MEDLINE | ID: covidwho-600948

Subject(s)

Antiviral Agents/chemistry; Antiviral Agents/therapeutic use; Betacoronavirus/chemistry; Betacoronavirus/drug effects; Coronavirus Infections/drug therapy; Pneumonia, Viral/drug therapy; COVID-19; Coronavirus/drug effects; Humans; Models, Molecular; Pandemics; Research; SARS-CoV-2; Structure-Activity Relationship

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Coronavirus Infections / Betacoronavirus Limits: Humans Language: English Journal: Curr Org Synth Year: 2020 Document Type: Article Affiliation country: 157017941703200610221527

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google